Tpp-CAQK TFA binds to mitochondria, facilitating the creation of Mito-Tpp-CAQK TFA, an engineered mitochondrial compound with excellent bioactivity. It's internalized by macrophages, enhancing myelin debris phagocytosis, alleviating mitochondrial dysfunction, and reducing proinflammatory profiles, ultimately aiding tissue repair and functional recovery in mice after spinal cord injury.
- Home
- Mitochondrial Diseases & Models
- By System Involvement
- Systemic Mitochondrial Disease
- Alpers Disease
- Barth Syndrome
- Carnitine Deficiency
- Creatine Deficiency Syndromes
- Co-Enzyme Q10 Deficience
- Friedreich’s Ataxia
- Kearns-Sayre Syndrome
- Lactic Acidosis
- Leigh Syndrome
- Mitochondrial DNA Depletion Syndrome
- MELAS Syndrome
- Multiple Mitochondrial Dysfunction Syndrome
- Short-Chain Acyl-CoA Dehydrogenase Deficiency
- Thymidine Kinase 2 Deficiency
- Mitochondrial Neurogastrointestinal Encephalopathy
- Organ-specific Mitochondrial Diseases
- Systemic Mitochondrial Disease
- By Etiology
- By System Involvement
- Solutions
- Products
- Mitochondrial Isolation Reagents & Kits
- Mitochondrial Staining Reagents & Kits
- Mitochondrial Disease Diagnostic Reagents & Kits
- Biochemical Inhibitors & Activators
- Mitochondrial Specific Antibodies
- Mitochondrial Recombinant Proteins
- Mitochondria Related Peptides
- Natural Products Targeting Mitochondria
- Resource
- Company